Lauras As

Life Science Nutrition As

Region Nordjylland

Pål Aukrust

Kjetil Taskén

Einar Martin Aandahl

Stig S Frøland

Vidar Hansson

Jo Klaveness

Rolf Kristian Berge

Aase Handberg

Michel Moutschen

Souad Rahmouni-Piette

Christian C Johansson

Bjørn S Skålhegg

Fredrik Müller

Bente Halvorsen

Mona Skjelland

The present invention relates to fatty acid analogues of the general formula R-[x-CH]&#x2014;COORand in particular to a method of treating inflammatory disorder selected from the group consisting of rheumatoid arthritis, systemic vasculitis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis, and polymyositis; comprising administering to a mammal in need thereof, an effective amount of tetradecylthioaceticacid or tetradecylselenoacetic acid; or a pharmaceutically acceptable salt thereof.

Fatty acid analogues for the treatment of inflammatory and autoimmune disorders

The present invention provides a method of treating or preventing a disorder typified by an immunodificiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluorophasphate. L-745337, rofecoxib, NS 398, SC 58125, etodolac, meloxicam, celecoxib or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment.

Methods of treating and preventing AIDS using of COX-2 inhibitors

Pharmaceutical compositions useful for treating immunosuppressive disease and containing compounds capable of inhibiting cAMP-dependent protein kinase A (PKA) as well as use of the same, are described.

Use of immunomodulating agents

Growing community of inventors

Ridabu, Norway

Pål Aukrust